Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Flexion Therapeutics Inc. FLXN

Healthcare Drug Manufacturers - Major
Flexion Therapeutics Inc is a United States-based specialty pharmaceutical company. The company focuses on the development and commercialization of novel, local therapies. The company specializes in the treatment of patients with musculoskeletal conditions beginning with osteoarthritis. The products offered by company are zilretta which is used for enhancing the clinical effect of intra... see more

Recent & Breaking News (NDAQ:FLXN)

Flexion Therapeutics to Present at Stifel 2015 Healthcare Conference

GlobeNewswire November 16, 2015

Flexion Therapeutics Reports Third-Quarter 2015 Financial Results

GlobeNewswire November 9, 2015

Technical Update on Stocks from Diverse Sectors - Research on ServiceSource International, Coeur Mining, Flexion Therapeutics, and Nanometrics

Accesswire November 5, 2015

Flexion Therapeutics to Report Third-Quarter 2015 Financial Results on November 9, 2015

GlobeNewswire November 2, 2015

Flexion Therapeutics Reports Top-Line Data From Pivotal Phase 2b Clinical Trial for FX006

GlobeNewswire September 8, 2015

Flexion Therapeutics Granted Fast Track Status by the FDA for FX006 for Treatment of Osteoarthritis of the Knee

GlobeNewswire September 1, 2015

Flexion Therapeutics Reports Second-Quarter 2015 Financial Results

GlobeNewswire August 6, 2015

Flexion Therapeutics Secures $30 Million in Debt Financing

GlobeNewswire August 4, 2015

Flexion Therapeutics Expands Supply Capacity for FX006 by Entering Into Agreement With Patheon

GlobeNewswire August 4, 2015

Flexion Therapeutics to Report Second-Quarter 2015 Financial Results on August 6, 2015

GlobeNewswire July 30, 2015

Flexion Therapeutics to Report Second-Quarter 2015 Financial Results on August 6, 2015

GlobeNewswire July 30, 2015

Flexion Therapeutics Completes Enrollment in Phase 3 Clinical Trial With Lead Compound FX006 in Patients With Osteoarthritis of the Knee

GlobeNewswire July 29, 2015

Flexion Therapeutics Completes Enrollment in Phase 3 Clinical Trial With Lead Compound FX006 in Patients With Osteoarthritis of the Knee

GlobeNewswire July 29, 2015

Flexion Therapeutics' Final FX006 Data From Completed Phase 2b Dose-Ranging Trial Published in Journal of Bone and Joint Surgery

GlobeNewswire June 3, 2015

Flexion Therapeutics Reports First-Quarter 2015 Financial Results

GlobeNewswire May 7, 2015

Flexion Therapeutics to Report First-Quarter 2015 Financial Results on May 7, 2015

GlobeNewswire April 30, 2015

Flexion Therapeutics Awarded Approximately $2 Million From U.S. Department of Defense to Conduct Clinical Trial of FX006 in Military Personnel With Osteoarthritis of the Knee

GlobeNewswire April 29, 2015

Flexion Therapeutics to Present at 14th Annual Needham Healthcare Conference

GlobeNewswire April 8, 2015

Flexion Reports Year-End 2014 Financial Results

GlobeNewswire March 23, 2015

Flexion Therapeutics to Report Year-End 2014 Earnings Results on March 23, 2015

GlobeNewswire March 16, 2015